JP2022525759A5 - - Google Patents
Info
- Publication number
- JP2022525759A5 JP2022525759A5 JP2021555545A JP2021555545A JP2022525759A5 JP 2022525759 A5 JP2022525759 A5 JP 2022525759A5 JP 2021555545 A JP2021555545 A JP 2021555545A JP 2021555545 A JP2021555545 A JP 2021555545A JP 2022525759 A5 JP2022525759 A5 JP 2022525759A5
- Authority
- JP
- Japan
- Prior art keywords
- powder
- crystal morphology
- ray diffraction
- morphology
- angles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025144862A JP2026004294A (ja) | 2019-04-10 | 2025-09-01 | ピリダジノンｔｒｐｃ阻害剤の結晶形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2019/081985 WO2020206623A1 (en) | 2019-04-10 | 2019-04-10 | Crystal forms |
| CNPCT/CN2019/081985 | 2019-04-10 | ||
| PCT/US2020/027689 WO2020210639A1 (en) | 2019-04-10 | 2020-04-10 | Crystal forms of a pyridazinone trpc inhibitor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025144862A Division JP2026004294A (ja) | 2019-04-10 | 2025-09-01 | ピリダジノンｔｒｐｃ阻害剤の結晶形態 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525759A JP2022525759A (ja) | 2022-05-19 |
| JP2022525759A5 true JP2022525759A5 (https=) | 2023-07-07 |
| JP7738482B2 JP7738482B2 (ja) | 2025-09-12 |
Family
ID=70482847
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021555545A Active JP7738482B2 (ja) | 2019-04-10 | 2020-04-10 | ピリダジノンｔｒｐｃ阻害剤の結晶形態 |
| JP2025144862A Pending JP2026004294A (ja) | 2019-04-10 | 2025-09-01 | ピリダジノンｔｒｐｃ阻害剤の結晶形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025144862A Pending JP2026004294A (ja) | 2019-04-10 | 2025-09-01 | ピリダジノンｔｒｐｃ阻害剤の結晶形態 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220177455A1 (https=) |
| EP (1) | EP3953352A1 (https=) |
| JP (2) | JP7738482B2 (https=) |
| CN (2) | CN114502552B (https=) |
| AU (1) | AU2026201003A1 (https=) |
| BR (1) | BR112021018221A2 (https=) |
| CA (1) | CA3136652A1 (https=) |
| MA (1) | MA55614A (https=) |
| MX (2) | MX2021012313A (https=) |
| WO (2) | WO2020206623A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3684364A4 (en) | 2017-09-18 | 2021-06-02 | Goldfinch Bio, Inc. | PYRIDAZINONE AND METHOD OF USE THEREOF |
| MA71645A (fr) * | 2018-09-18 | 2025-05-30 | Goldfinch Bio, Inc. | Pyridazinones et leurs procédés d'utilisation |
| US12576033B2 (en) * | 2019-04-11 | 2026-03-17 | Gfb (Abc), Llc | Spray-dried formulation of a pyridazinone TRPC5 inhibitor |
| JP2022551580A (ja) * | 2019-10-04 | 2022-12-12 | ゴールドフィンチ バイオ，インク． | 巣状分節性糸球体硬化症および糖尿病性腎症のバイオマーカーに基づく処置 |
| JP7539545B2 (ja) * | 2020-07-03 | 2024-08-23 | 武漢朗来科技発展有限公司 | 複素環化合物及びその使用 |
| US20250122190A1 (en) * | 2021-09-10 | 2025-04-17 | Medshine Discovery Inc. | Halogen-substituted pyridazinone compound and application thereof |
| US20250082655A1 (en) * | 2022-01-27 | 2025-03-13 | Wuhan Createrna Science And Technology Co., Ltd. | Use of heterocyclic compound |
| WO2024027752A1 (zh) * | 2022-08-05 | 2024-02-08 | 武汉朗来科技发展有限公司 | 包含杂环化合物的药物组合物及其制备方法和应用 |
| WO2025250920A1 (en) | 2024-05-31 | 2025-12-04 | Gfb (Abc), Llc | Pyridazinone phosphate compounds, pharmaceutical compositions, and medical uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPP310798A0 (en) * | 1998-04-22 | 1998-05-14 | Soltec Research Pty Ltd | Vehicle system for a composition comprising a piperidinopyrimidine derivative |
| US8633233B2 (en) * | 2008-08-06 | 2014-01-21 | Hydra Biosciences, Inc. | Methods and compositions for treating anxiety |
| WO2016023830A1 (en) * | 2014-08-11 | 2016-02-18 | Hydra Biosciences, Inc. | Pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dione derivatives |
| EP3684364A4 (en) * | 2017-09-18 | 2021-06-02 | Goldfinch Bio, Inc. | PYRIDAZINONE AND METHOD OF USE THEREOF |
| MA71645A (fr) * | 2018-09-18 | 2025-05-30 | Goldfinch Bio, Inc. | Pyridazinones et leurs procédés d'utilisation |
-
2019
- 2019-04-10 WO PCT/CN2019/081985 patent/WO2020206623A1/en not_active Ceased
-
2020
- 2020-04-10 JP JP2021555545A patent/JP7738482B2/ja active Active
- 2020-04-10 US US17/603,249 patent/US20220177455A1/en active Pending
- 2020-04-10 EP EP20723672.0A patent/EP3953352A1/en active Pending
- 2020-04-10 MX MX2021012313A patent/MX2021012313A/es unknown
- 2020-04-10 CN CN202080042302.9A patent/CN114502552B/zh active Active
- 2020-04-10 CA CA3136652A patent/CA3136652A1/en active Pending
- 2020-04-10 CN CN202411019840.2A patent/CN119264134A/zh active Pending
- 2020-04-10 WO PCT/US2020/027689 patent/WO2020210639A1/en not_active Ceased
- 2020-04-10 MA MA055614A patent/MA55614A/fr unknown
- 2020-04-10 BR BR112021018221A patent/BR112021018221A2/pt unknown
-
2021
- 2021-10-07 MX MX2025006384A patent/MX2025006384A/es unknown
-
2025
- 2025-09-01 JP JP2025144862A patent/JP2026004294A/ja active Pending
-
2026
- 2026-02-11 AU AU2026201003A patent/AU2026201003A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022525759A5 (https=) | ||
| CN116568689B (zh) | 一种作为sos1抑制剂的多环嘧啶类衍生物、其制备方法及用途 | |
| TWI287545B (en) | New pyridazin-3(2h)-one derivatives | |
| EP2600719B1 (en) | 2-substituted-8-alkyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidine-6-carbonitriles and uses thereof | |
| JP2022520382A5 (https=) | ||
| CN114728912A (zh) | Mta-协同prmt5抑制剂 | |
| TW200938545A (en) | New compounds for the treatment of CNS disorders | |
| CN116669738A (zh) | 一种作为sos1抑制剂的嘧啶并吡啶酮类衍生物、其制备方法及用途 | |
| TW201100426A (en) | New compounds for the treatment of CNS disorders | |
| TWI303634B (en) | 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,4']bipyridinyl in pure crystalline form, process for synthesis, and pharmaceutical composition containing the same | |
| TW201215595A (en) | Therapeutic compounds | |
| CN103261167A (zh) | 取代的6，6-稠合含氮杂环化合物及其用途 | |
| TWI295671B (en) | Tricyclic tetrahydroquinoline antibacterial agents | |
| EA025863B1 (ru) | Карбазолкарбоксамидные соединения | |
| TW200904817A (en) | Compounds and uses thereof | |
| TW200811153A (en) | 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor | |
| CN109863137A (zh) | Lsd1抑制剂及其医学用途 | |
| JP2020536893A5 (https=) | ||
| TW200804287A (en) | Tetrahydronaphthalene derivatives, processes for preparing them and their use as antiinflammatory agents | |
| KR20170068596A (ko) | 트리시클릭 회전장애이성질체 화합물 | |
| TW200808317A (en) | Compounds for treating pulmonary hypertension | |
| Song et al. | Synthesis, cytotoxic activity evaluation of novel 1, 2, 3‐triazole linked quinazoline derivatives | |
| JP2024514090A5 (https=) | ||
| JP2003514859A5 (https=) | ||
| JP2019536759A (ja) | 置換された二環式ヘテロアリール系ニコチン性アセチルコリン受容体アロステリック調節剤 |